UNSPSC 51171635: Bisoxatin

This classification denotes an oxazine with the molecular formula C20H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C75N0L7FP, chemically known as 2,2-bis(p-hydroxyphenyl)-3-oxo-dihydrobenzoxazin-(1,4) but generally known as bisoxatin, which bears US NIH Compound Identifier 28689. bisoxatin most often comes in base and acetate forms. European Medicines Agency schedules Bisoxatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05856MIG.

UNSPSC 51171635 Bisoxatin is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement. The sole recent opportunity tagged to this code is Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services, a forensic and clinical laboratory testing operation that falls outside the pharmaceutical active-ingredient scope the code's name implies. The county seeks a vendor to staff two collection sites in Plano and McKinney, operate randomized testing notification systems, perform immunoassay screening with LC/MS/MS or GC/MS confirmation, conduct electronic result reporting, and offer alternative testing methodologies including oral fluid and hair testing. Annual demand is approximately 25,031 tests across five-panel and six-panel screening formats and ancillary testing. The vendor must hold lab certification from SAMHSA, TX DPS, or CAP. This is a single county-level procurement, not a pattern of activity across multiple jurisdictions or issuing-body types.

The activity is limited to Texas, specifically Collin County. Collin County issued RFP 2026-327 with a response due July 23, 2026, an estimated contract value of $600,000, and a two-year term commencing September 1, 2026, with three optional one-year renewals not to exceed five years total. Pricing is per-test based, covering screening only, confirmation after screening, or screening with automatic confirmation of positives, with all freight, delivery, insurance, and staffing costs included. Evaluation comprises compliance review, Phase 1 scoring (vendor understanding 30 points, firm qualifications 25 points, client references 15 points, cost 30 points), and optional Phase 2 demonstrations and interviews up to 30 points. The anticipated award date is August 10, 2026. Funding derives from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations, subject to annual availability. The code shows no broader recent activity and appears to be a misclassification for this opportunity.